Student wrote:EveningWood wrote:Hi Student,
Please update this thread if/when you receive an answer, it would be interesting for at least a few people.
Take care,
EveningWood
Hello
I find this
It was an article in french i translate with google translate
""""How did 2020 go and what do you plan for 2021?
2020 has surprisingly been a good year for Comphya. Our product has matured, we have consolidated our regulatory and technical file, and we are in the final stages of clinical validation. An independent Clinical Advisory Board is now helping to shape the clinical development of the company and we have increased protection for the patent portfolio. And Comphya raised $ 1.3 million in the form of Bridge Financing - including the loan from FIT.
2021 will be crucial for Comphya, with a clinical trial planned in the United States for patients who have undergone prostatectomy, and another in Switzerland for patients with spinal cord injuries. By the end of 2021, Comphya also aims to raise $ 15 million in Series A to complete the pivotal study, obtain marketing approval and expand the team.
https://www.google.com/amp/s/amp.issuu. ... s/11732832
Hi Student.
Thanks for the info. Seems though that 2021 would be a bit early for them to be ready.
Will be monitoring this.
Best regards,
EveningWood
